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PURPOSE
Test experimental parameters in order
to optimize ZnO nanoparticles as a
matrix for detection of low molecular
weight neurochemicals in rat and mouse
brain tissue.

BACKGROUND

INSTRUMENTATION

MALDI-MS is an analytical technique used
to ionize analyte samples into charged
molecules.

A brief overview of instruments used and
their purpose relative to the goal of the
experiment at hand.
HTX TM Sprayer : Instrument used to
spray a uniform matrix coating onto
conductive ITO glass slides with brain
tissue.

Figure 1. Principle of Matrix Assisted Laser
Desorption/Ionization (MALDI-MS)

A brief 350 nm UV laser pulse is applied onto a
target plate and absorbed by matrix particles.
Vibrational excitation allows analytes
embedded in the matrix particles to be carried
into the gas phase, where they are ionised by
protonation or deprotonation and sent to the
Time of Flight (TOF) mass analyser.
Analyte ions are accelerated
under an applied potential and
fixed kinetic energy such that
the time it takes for ions to
reach the detector direcly
correlates to their mass-tocharge ratio. Lighter molecular
weight ions reach the detector
faster.

Figure 2. SCIEX TOF/TOF 5800 MALDIMS System

The results are presented
on a mass spectrum that
exhibits intensity of the
signal as a function of the
m/z of the analyte ions.

Figure 3. HTX TM Sprayer

DeNovix DS-11 Nanodrop :
Instrument used for
microvolume analysis of
diluted ZnO nanoparticle
solutions in order to
determine matrix
concentrations from UV
absorbance.
Figure 4. Microvolume
UV-Vis Instrument

Zetasizer Nano Dynamic Light
Scattering Instrument : Instrument
used for determining size
distribution of nanoparticles
including the formation and
disappearance of aggregates
in sample
Figure 5. Zetasizer Nano DLS
Instrument

EXPERIMENTAL RESULTS
SAMPLE PREPARATION
Stock concentration determined to be 20.6
mg/mL by drying 100 µL of ZnO suspension
and monitoring its weight for multiple days.

ZnO nanoparticle solution was diluted 40x :

25 µL of stock suspension + 975 µL of
MilliQ H20
ZnO nanoparticles have a tendency to form
large clusters over time upon exposure to light
and heat. These aggregates risk to clog the
HTMX sprayer, resulting in costly damage.

To prevent this, ZnO nanoparticle solutions
were filtered prior to spraying.

Figure 6. Size distribution by intensity of non-filtered ZnO
nanoparticles, aggregates circled

FILTER
PROPERTIES
IC Millex,
Hydrophilic
PTFE
Membrane
0.45 µm,
syringe filter
(25 mm)

Millipore
Mixed
Cellulose
Esters
Membrane
0.65 µm,
vacuum filter
(25 mm)

Cytvia
Whatman
Hydrophobic
PTFE
Membrane
1.0 µm,
syringe filter
(13 mm)

RESULTS
Average np size = 135.7 d.nm
Percent np recovery = 4%
Minimal background signal
from filter material
Consistent size distribution
without aggregates but low UV
absorbance
Average np size = 270.1 d.nm
Percent np recovery = 85%
Significant background signal
but no signal overlap with
analytes
Inconvenient method with
risk of procedural error
Consistent size distribution
without aggregates

NUMBER OF PASSES & SIGNAL STRENGTH
HTX TM Sprayer Settings
Solvent : 50% ACN
Temperature: 65°C
Pressure : 10 psi
Matrix Conc.: 5 mg/mL
Flow Rate: 0.05 mL/min Velocity: 1200 mm/min
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Figure 8. Brain tissue sections on ITO glass slides with digits
corresponding to number of passes of matrix coated on tissue
and grid showing nozzle pathway with 3 mm spacing

Average np size = 243.5 d.nm
Percent np recovery = 92%
Minimal background signal
from filter material
Inconsistent filtrate colours
and np size distribution
despite consistent
preparation
Figure 9. The effect of the number of passes of 5 mg/mL ZnO on
various analyte signals

Only 1 mL of solution per filter in order to prevent
accumulation of aggregates on film, affecting
recovery and reproducibility.
Three filter pore sizes, 0.45 µm, 0.65 µm and 1.0
µm, were assessed based on nanoparticle
retention, background signal, reproducibility and
ability to sift out large aggregates.
Comparison of calibration curve data from
UV-Vis testing for non-filtered ZnO and filtered
ZnO solutions allowed for the calculation of %
recovery.

Matrix concentration of filtered nanoparticles
found to be optimal between 2-5 mg/mL
through performance of numerous spot tests
while observing signal intensity changes of
known neurochemical standard.

Figure 7. Size distribution by intensity of non-filtered ZnO
nanoparticles (light green) vs 0.65 µm filtered ZnO nanoparticles (red)

SAMPLE CONCENTRATION
Matrix concentration previously optimized at 1
mg/mL dissolved in 50% ACN for non-filtered
ZnO nanoparticles.

Figure 10. Heat maps showing regions of high intensity for [GABA +
K] (left) and [Glutamate + K] (right) for 5 mg/mL of ZnO and 12 passes

FUTURE WORK

More testing to be done in order to further optimize
ZnO for concentrations < 5 mg/mL to ensure
reproducibility with sprayer and apply developed
metholody to answer biochemical research questions.

